Please assess the completion status of the following clinical trial:

Trial Title: Cardiomyopathy in Steroid-resistant Nephrotic Syndrome: Impact of Focal Segmental Glomerulosclerosis

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age 6 months - 21 years~* SRNS, defined as failure to achieve remission in proteinuria after 4-6 weeks of daily steroid therapy in accord with ISKDC guidelines~* GFR \> 30 ml/min/1.73 m\^2~* Renal disease diagnosed based on kidney biopsy~Exclusion Criteria:~* Secondary FSGS~* Prior renal transplantation~* Congenital extra-renal abnormalities~* Significant structural cardiac abnormalities~* pulmonary, hematologic, malignancy, or immune-related disease~* inability to maintain adequate follow-up

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 21 Years
- Healthy Volunteers: f

Study Arms:
- Focal Segmental Glomerulosclerosis (Type: None): None
- Non-Focal Segmental Glomerulosclerosis (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).